Testing effectiveness (Phase 2)UnknownNCT01964534
What this trial is testing
Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Who this might be right for
Metastatic Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 114